← Open Payments lookup

DENISE CORRIVEAU: Open Payments

NPI 1902420938 · SAN DIEGO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,463 in 71 payments from 16 companies in 2025. Trend: 2023 $1,639 · 2024 $3,940 · 2025 $1,463

Food & beverage: $1,463
CompanyPaymentsAmount
ABBVIE INC.22$310
Takeda Pharmaceuticals U.S.A., Inc.6$217
Janssen Biotech, Inc.12$213
Regeneron Healthcare Solutions, Inc.7$200
Salix Pharmaceuticals, a division of Bausch Health US, LLC11$189
GENZYME CORPORATION3$110
Lilly USA, LLC1$32
Braintree Laboratories, Inc.1$30
AstraZeneca Pharmaceuticals LP1$29
Ipsen Biopharmaceuticals, Inc1$22

Products named: DUPIXENT, TREMFYA, ENTYVIO, XIFAXAN, LINZESS, RINVOQ, CREON, OMVOH.

Industry payments across CA — which companies pay providers there.